Advanced glycation endproducts (AGEs) as uremic toxins

Nahrung. 2001 Jun;45(3):172-6. doi: 10.1002/1521-3803(20010601)45:3<172::AID-FOOD172>3.0.CO;2-U.

Abstract

Products of non-enzymatic glycation accumulate both in diabetic and non-diabetic patients with renal failure. The increase in concentration is presumably due to increased generation, secondary to oxidative stress and due to decreased (renal) elimination; whether accumulation of AGEs of dietary origin plays a role is currently under investigation. AGE's have been related to progression of diabetic (and possibly also non-diabetic) renal disease and to a number of complications of the uremic syndrome. These comprise beta-2-microglobulin-derived dialysis-related amyloidosis, dyslipidemia, vascular dysfunction and accelerated atherogenesis. A specific case is AGE related damage to the peritoneal membrane in CAPD patients. Removal of AGE by dialysis is negligible and even high flux dialysis eliminates only a quantitatively limited amount of AGE. In contrast, a rapid decrease of AGE concentrations in plasma is noted after renal transplantation. Dietary AGEs may contribute significantly to the total AGE load of the body, particularly in uremia.

Publication types

  • Review

MeSH terms

  • Diabetic Nephropathies / etiology*
  • Disease Progression
  • Glycation End Products, Advanced / adverse effects
  • Glycation End Products, Advanced / blood
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Maillard Reaction*
  • Peritoneal Dialysis, Continuous Ambulatory
  • Renal Insufficiency / etiology
  • Toxins, Biological / metabolism*
  • Uremia / complications
  • Uremia / etiology*
  • Uremia / therapy

Substances

  • Glycation End Products, Advanced
  • Toxins, Biological